Bristol-Myers Squibb - Company Snapshot & SWOT Analysis
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Their medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. The company operates in one business segment i.e. Biopharmaceuticals. Their four strategic priorities are to drive business performance, continue to further build a leading franchise in IO, maintain a diversified portfolio both within and outside of IO, and continue our disciplined approach to capital allocation, including establishing partnerships, collaborations and in-licensing or acquiring investigational compounds as an essential component of successfully delivering transformational medicines to patients. The company manufacture products in the U.S., Puerto Rico and in four foreign countries. Most of their revenues come from products in the following therapeutic classes: oncology; cardiovascular and immunoscience
Bristol-Myers Squibb reported revenue of USD 22.561 billion for the FY 2018 which saw an increase of 8.59% compared to FY 2017. This revenue is expected to decrease by 5% and reach USD 23.689 billion by FY 2019. Bristol-Myers Squibb revenue grew at a CAGR of 6.61% during FY 2013 to FY 2018.
Bristol-Myers Squibb registered highest revenue from United States market at USD 12.586 billion which accounted for 55.79% of its total revenue in FY 2018.
Scope of the Bristol-Myers Squibb Company - Company Snapshot & SWOT Analysis Report
Bristol-Myers Squibb reported revenue of USD 22.561 billion for the FY 2018 which saw an increase of 8.59% compared to FY 2017. This revenue is expected to decrease by 5% and reach USD 23.689 billion by FY 2019. Bristol-Myers Squibb revenue grew at a CAGR of 6.61% during FY 2013 to FY 2018.
Bristol-Myers Squibb registered highest revenue from United States market at USD 12.586 billion which accounted for 55.79% of its total revenue in FY 2018.
Scope of the Bristol-Myers Squibb Company - Company Snapshot & SWOT Analysis Report
- This report provides detailed information about Bristol-Myers Squibb Company including value chain analysis, financial performance, business strategy and SWOT analysis.
- The report identifies the growth drivers and inhibitors for global pharmaceutical market.
- This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY
Scope of the Bristol-Myers Squibb Company - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Bristol-Myers Squib Company
3.1.1 Company Profile
3.1.2 Bristol-Myers Squibb Company in Pharmaceuticals Manufacturing Value Chain
3.1.3 Bristol-Myers Squibb Company: Financial Performance
3.1.3.1 Bristol-Myers Squibb Company: Overall Revenue FY 2013-FY 2019 (in USD billion)
3.1.3.2 Bristol-Myers Squibb Company: Geography-Wise Revenue FY 2018 (in USD billion)
3.1.3.3 Bristol-Myers Squibb Company: Brand-Wise Pharmaceuticals Revenue FY 2018 (in USD billion)
3.1.4 Bristol-Myers Squibb Company: Business Strategy
3.1.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Bristol-Myers Squibb Company
Strengths
Weaknesses
Opportunities
Threats
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES/ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
Scope of the Bristol-Myers Squibb Company - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Bristol-Myers Squib Company
3.1.1 Company Profile
3.1.2 Bristol-Myers Squibb Company in Pharmaceuticals Manufacturing Value Chain
3.1.3 Bristol-Myers Squibb Company: Financial Performance
3.1.3.1 Bristol-Myers Squibb Company: Overall Revenue FY 2013-FY 2019 (in USD billion)
3.1.3.2 Bristol-Myers Squibb Company: Geography-Wise Revenue FY 2018 (in USD billion)
3.1.3.3 Bristol-Myers Squibb Company: Brand-Wise Pharmaceuticals Revenue FY 2018 (in USD billion)
3.1.4 Bristol-Myers Squibb Company: Business Strategy
3.1.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Bristol-Myers Squibb Company
Strengths
Weaknesses
Opportunities
Threats
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES/ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
LIST OF EXHIBITS
Exhibit 3.1 Key Information of Bristol-Myers Squib Company
Exhibit 3.2 Contact Information of Bristol-Myers Squib Company
Exhibit 3.3 Bristol-Myers Squib Company in Global Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Revenue of Bristol-Myers Squibb Company FY 2013-FY 2019 (in USD billion)
Exhibit 3.5 Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2019 (in %)
Exhibit 3.6 Geography-Wise Revenue of Bristol-Myers Squibb Company in FY 2018 (in USD billion)
Exhibit 3.7 United States Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.8 United States Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.9 Europe Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.10 Europe Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.11 Rest of World Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.12 Rest of World Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.13 Other Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.14 Other Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.15 Brand-Wise Pharmaceuticals Revenue of Bristol-Myers Squibb Company FY 2018 (in USD billion)
Exhibit 3.16 SWOT Analysis of Bristol-Myers Squib Company
Exhibit 3.1 Key Information of Bristol-Myers Squib Company
Exhibit 3.2 Contact Information of Bristol-Myers Squib Company
Exhibit 3.3 Bristol-Myers Squib Company in Global Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Revenue of Bristol-Myers Squibb Company FY 2013-FY 2019 (in USD billion)
Exhibit 3.5 Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2019 (in %)
Exhibit 3.6 Geography-Wise Revenue of Bristol-Myers Squibb Company in FY 2018 (in USD billion)
Exhibit 3.7 United States Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.8 United States Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.9 Europe Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.10 Europe Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.11 Rest of World Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.12 Rest of World Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.13 Other Revenue of Bristol-Myers Squibb Company FY 2013-FY 2018 (in USD billion)
Exhibit 3.14 Other Revenue Growth of Bristol-Myers Squibb Company FY 2014-FY 2018 (in %)
Exhibit 3.15 Brand-Wise Pharmaceuticals Revenue of Bristol-Myers Squibb Company FY 2018 (in USD billion)
Exhibit 3.16 SWOT Analysis of Bristol-Myers Squib Company
